Atlas Trials

Uncommon EGFR Mutations

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Uncommon EGFR Mutations

RecordFirmDate
A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection (NCT07128199)Taiho Oncology, Inc.2025-12-22

Track Uncommon EGFR Mutations automatically

Every clearance here is in the API, with alerts when new ones post.